都说创业很难，在创业期间遇到的问题都是前所未有的，在大多数创业者所遇到的问题中，股权分配是让大家最头疼的问题。

为此，我们特意邀请了康桥资本(CBC Group)投资副总裁陈家岐博士（Stephen Chan）以“创业公司如何进行股权设计”为主题为初期创业者分享相关的内容，以期能够帮助生物医疗领域创业者解决创业初期的实际性问题。

活动主题

创业公司如何进行股权设计？

➤ Different types of shares in a company, how do they differ from each other?

➤ What is the right share equity for founders?

➤ How to incentives the team with shares equity?

➤ How to deal with leavers with ESOP?

➤ Key considerations when engaging with VC for financing, what are the potential pitfalls and things to watch out?

时间及地点

日期及时间：

2021-05-29 10:30AM BJT

2021-05-28 7:30PM PDT

2021-05-28 10:30PM EDT

地点：zoom线上会议室

语言：英文

主讲人

陈家岐博士（Stephen Chan）

康桥资本投资副总裁

陈家岐博士（Stephen Chan）目前是康桥资本(CBC Group)医药行业的投资副总裁。康桥资本是一家以医疗保健为重点的私募股权基金，管理着超过35亿美元的资产。在康桥资本，陈家岐博士主要专注于跨新兴技术前沿的新公司孵化，特别关注基因和细胞治疗领域。

在加入康桥资本之前，陈家岐博士曾领导和高资产管理有限公司（Co-High Investment）的医疗健康投资团队，和高资产管理有限公司总部位于香港，由西泽投资管理公司（Atlantis Investment）所投资。在和高资产管理有限公司，陈家岐博士管理着1亿美元规模的医疗基金，他曾投资的公司包括：Oxford Nanopore、Sera Pronotics、Promethera Biosciences。

在加入和高资产管理有限公司之前，陈家岐博士是麦肯锡公司(Mckinsey & Company)的高级战略顾问，为全球制药公司提供研发和战略投资咨询服务。陈家岐博士本科毕业于伦敦帝国学院生物化学专业，博士就读于剑桥大学，并获得遗传学博士学位，曾获取裘槎奖学金（Croucher Scholarships）。

英文介绍：

Stephen currently serves as Investment Vice President (Pharma) at CBC Group, a leading healthcare focused private equity firm with over US$3.5Bn AUM. At CBC, Stephen mainly focused on new company incubation across multiple emerging technology fronts with a particular focus on gene and cell therapy. Prior to CBC Group, Stephen heads the Healthcare Investment team of Co-High Investment, a private equity and venture investment arm of Hong Kong based Atlantis Investment. At Co-High, Stephen manages a dedicated US$100Mn healthcare fund, his selected prior investment includes, Oxford Nanopore Technologies, Sera Prognostics, Promethera Biosciences. Before Co-High, Stephen was a senior Strategy Consultant at Mckinsey & Co. where he advised global pharmacos on R&D and investment strategy. Stephen graduated with a Ph.D. in genetics from The University of Cambridge, where he was also a Croucher Scholar; he also obtained a 1st class B.Sc. in Biochemistry from Imperial College London.

关于康桥资本(CBC Group)：

康桥资本(CBC Group)是亚洲最大和最活跃的医疗健康行业的私募股权基金之一，专注于生物医药、医疗器械和医疗服务三个核心领域的平台建设和收购机遇。康桥资本赋能医疗健康行业领军企业的变革，以实现长期可持续增长，解决尚未满足的医疗需求，不断提高中国和亚洲其他地区的全民医疗健康水平及生活质量。康桥资本成立于2014年，在新加坡、上海、北京、香港和纽约拥有强大的投资、医疗和投资组合管理的专业团队。

About CBC Group

CBC Group (formerly C-Bridge Capital) is one of the largest and most active healthcare-dedicated investment firms in Asia focused on platform-building and buyout opportunities across three core areas within the healthcare sector: pharmaceutical & biotech, medtech and healthcare services. CBC’s operationally intensive approach empowers healthcare sector champions to make transformative changes to enable sustainable long-term growth, fulfill unmet medical needs and continuously improve the standard of living and quality of care in China and the rest of Asia. Founded in 2014, CBC has a strong team of investment, healthcare and portfolio management professionals based across Singapore, Shanghai, Beijing, Hong Kong and New York.

活动流程

10:30~10:35 主持人开场 

10:35~11:05 嘉宾主题演讲 

11:05~11:25 Q&A环节 

11:25~11:30 主持人结束词 

联合主办方